Yunlong Richard Cao on X: It's critical to test how these RBD hotspots could combine to achieve max immune evasion without losing affinity to ACE2. After careful consideration, besides the emerging K478R/F456L

The Potential for SARS-CoV-2 to Evade Both Natural and Vaccine-induced Immunity

Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

Thread by @yunlong_cao on Thread Reader App – Thread Reader App

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

Frontiers Nanobodies: COVID-19 and Future Perspectives

Yunlong Cao Lab Peking University

Immune evasion and ACE2 binding affinity contribute to SARS-CoV-2 evolution

The Potential for SARS-CoV-2 to Evade Both Natural and Vaccine-induced Immunity

Immune evasion and ACE2 binding affinity contribute to SARS-CoV-2 evolution

Yunlong Cao Lab Peking University

The Potential for SARS-CoV-2 to Evade Both Natural and Vaccine-induced Immunity